Juergen Willmann, MD

Professor of Radiology

Division Chief, Body Imaging
Stanford University School of Medicine

Stanford Profile | Research

Phone: 650-725-1812 | Fax: 650-723-1909 | E-mail »

Lofti Abou-Elkacem, PhD

E-mail »

"My goal is the detection of early pancreatic cancer using a novel non-invasive in vivo molecular ultrasound imaging technique. The diagnostic accuracy of molecular ultrasound imaging will be assessed in detecting early pancreatic cancer by using a novel molecular target in a transgenic pancreatic cancer mouse model."

Sunitha Bachawal, PhD

(650) 724-1472 | E-mail »

"The focus of my research is using novel non-invasive in vivo molecular imaging techniques for early detection and treatment monitoring of breast cancer. In addition I work on identifying new molecular targets for use with ultrasound imaging."

Ahmed El Kaffas, PhD

"I am interested in developing imaging methods to characterize tumor vasculature and the tumor microenvironment, and to subsequently relate these imaging methods to biomarkers that can be used for cancer treatment monitoring. My current research is focused on developing volumetric contrast-enhanced quantitative ultrasound methods to characterize tumour vasculature and to assess treatment response in patents with colorectal cancer metastases in the liver."

Taehwa Lee, PhD

E-mail »

My research interest is in cavitation-based therapeutic modalities enabled by focused ultrasound produced by either laser excitation or piezoelectric transducers, with an aim of treating diseased tissues in non-invasive and targeted manners. I am currently working on image-guided ultrasound/microbubble-meditated drug delivery with an emphasis on passive cavitation imaging for monitoring drug delivery.

Sayan Mullick-Chowdhury, PhD

I am currently working on developing highly efficacious imaging guided delivery strategies for drug and miRNA mediated therapy of hepatocellular carcinoma. The primary focus of my research is to overcome HCC associated drug resistance to achieve better therapeutic outcomes.

Rosa Sigrist, MD

My research interest is in clinical projects using non-invasive imaging techniques such as 3D-Contrast Enhanced Ultrasound for GI cancer treatment monitoring of patients with liver metastases. I am also interested in Ultrasound Elastography for characterizing focal and diffuse diseases of the liver and focal lesions of the kidney.

Keerthi Valluru, MS

I am extremely passionate about medical imaging systems and techniques that are specifically aimed toward obtaining physiological information in vivo. My primary research interest is to identify pathophysiological changes associated with cancer using molecular imaging principles and quantify them. My interests also include multimodality imaging with emphasis on early cancer diagnosis and screening, fusion imaging and quantitative image analysis.

Huaijun (Morgan) Wang, PhD

(650) 724-1472 | E-mail »

"My research interests are the characterization of different rodent and large animal models and therapeutic evaluation of diseases with multiple imaging modalities including ultrasound, magnetic imaging resonance, computed tomography, and positron emission tomography with special focus on molecular imaging, including early detecting tumor and monitoring treatment response in rodent tumor models."

Katheryne Wilson, PhD

"My primary research interest is focused on using multi-modality imaging, with a large emphasis on ultrasound and photoacoustics, combined with molecular contrast agents to address clinical needs, such as early as possible breast cancer detection and imaging of inflammation. I have a strong interest in the combination of molecular imaging and nanotechnology to create novel imaging agents."

Jennifer Wischhusen, PhD

"In my PhD, I use ultrasound contrast agents, so-called microbubbles, for ultrasound molecular imaging, gene delivery, and drug delivery. I study ultrasound molecular imaging as a companion diagnostic for a new drug target in breast cancer. Ultrasound gene delivery is evaluated as a tool for the study of non-human primate brain development. During my one-year visit at the TMIL, I will work on ultrasound drug delivery for the improvement of therapy response in hepatocellular carcinoma."

Huiping Zhang, MD, PhD

E-mail »

My research interest is focused on the early evaluation of anti-cancer treatment on mice tumor models, including colon cancer and hepatic cancer, using three-dimensional ultrasound molecular imaging with the quantitative analysis and the detection of circulation tumor cells.

Lab Alumni

Rosa Sigrist, MD

Huiping Zhang, MD, PhD

Ferdinand Knieling, PhD

Steven Machtaler, PhD

Jiale Qin, MD

Tzu Yin Wang, PhD

Jianhua Zhou, PhD

Osamu Kaneko, MD

Paul Laeseke, PhD

Nirupama Deshpande, PhD

Marybeth Pysz, PhD

Kira Foygel, PhD

Ying Ren

Cedric Panje

Grace Anlon Tye

Anobel Tamrazi

David Wang